^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

FGF (Fibroblast Growth Factor)

i
Other names: FGF, Fibroblast Growth Factor
8d
The Regenerative Effects of Intracordal Injection of Basic Fibroblast Growth Factor for Vocal Fold Scar After Burn or Radiotherapy: A Preliminary Report. (PubMed, J Voice)
This preliminary report suggests that intracordal bFGF injection may be effective for some cases even with severe vocal fold scar caused by radiotherapy, while the effects for burn-related scar remain unclear. Further investigation in a larger cohort is warranted to explore more information about the therapy.
Journal
|
FGF (Fibroblast Growth Factor)
|
Akeega (abiraterone/niraparib)
13d
Distinct roles for SETα and SETβ in early cell fate decisions. (PubMed, Nucleic Acids Res)
As KLF5 specifically regulates SETα, this implicates SET isoform switching at the KLF5/FGF signalling axis during primitive endoderm specification. Together, we propose a model of how distinct roles of SETα and SETβ may regulate cell identity in the early blastocyst.
Journal
|
FGF4 (Fibroblast growth factor 4) • FGF (Fibroblast Growth Factor)
21d
Effects of cardiopulmonary bypass on in vitro proliferation of human pancreatic cancer cells and plasma growth factor levels. (PubMed, J Cardiothorac Surg)
These results suggest that cardiac surgery with CPB increases the plasma levels of several growth factors, thus potentially promoting pancreatic cancer cell proliferation, as seen in the in vitro study using serum from non-cancer patients.
Preclinical • Journal
|
HGF (Hepatocyte growth factor) • IGF2 (Insulin-like growth factor 2) • FGF (Fibroblast Growth Factor)
25d
In Vitro Analysis of TWEAK/Fn14 Axis in the Blood-Brain Barrier Models during Oxygen-Glucose Deprivation and Reoxygenation. (PubMed, Mol Neurobiol)
The findings indicate a time-dependent regulation of Fn14 under ischemic conditions in vitro, highlighting its role in BBB stress and recovery. Nevertheless, further preclinical studies are needed to establish its therapeutic potential.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • FGF (Fibroblast Growth Factor) • TJP1 (Tight Junction Protein 1) • CDH5 (Cadherin 5) • OCLN (Occludin)
26d
Profiles of Growth Factors Secreted by In Vitro-Stimulated Paediatric Acute Leukaemia Blasts of Myeloid and Lymphoid Origin. (PubMed, Int J Mol Sci)
Lineage-specific responses may be exploitable for targeted therapeutic approaches for distinct AL types. This study is the first to comprehensively assess the extracellular secretion of multiple GFs by paediatric AL cells in cultures using a Bio-Plex multiplex immunoassay.
Preclinical • Journal
|
VEGFA (Vascular endothelial growth factor A) • CSF2 (Colony stimulating factor 2) • FGF (Fibroblast Growth Factor)
1m
Glycosaminoglycan-Inspired Polymer Brushes Promote Human Mesenchymal Stem Cell Proliferation While Retaining Trilineage Differentiation Potential. (PubMed, ACS Appl Mater Interfaces)
Finally, hMSCs expanded on S75H25 were successfully differentiated into adipogenic, chondrogenic, and osteogenic cell types. We engineered chemically defined and highly economical GAG-mimetic cell culture substrates based on sulfonated polymer brushes that can be readily applied to biomanufacturing platforms such as spinner flasks, bioreactor beads, and microfluidic platforms to boost hMSC throughput under fully defined conditions.
Journal
|
CDK2 (Cyclin-dependent kinase 2) • FGF (Fibroblast Growth Factor) • ITGA6 (Integrin, alpha 6)
2ms
Recent trend on sarcoma stem cell reprogramming towards study of disease progression: A systematic review. (PubMed, J Stem Cells Regen Med)
Furthermore, the addition of growth factors such as bFGF, EGF, or FGF significantly enhanced the formation of CSCs' spheroids. Most of the studies included in the review utilized a non-viral vector for the delivery of pluripotent gene markers into the cells.
Review • Journal
|
EGF (Epidermal growth factor) • FGF (Fibroblast Growth Factor)
2ms
Fibrin hydrogel incorporated with microspheres containing vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) accelerated the healing of diabetic wounds in rats. (PubMed, Tissue Cell)
This multimodal approach holds promise as a potential therapeutic strategy for chronic diabetic wounds, offering both functional and structural benefits. Further long-term studies and clinical translation are warranted to evaluate safety and efficacy in human patients.
Preclinical • Journal
|
VEGFA (Vascular endothelial growth factor A) • TNFA (Tumor Necrosis Factor-Alpha) • FGF (Fibroblast Growth Factor) • TGFB1 (Transforming Growth Factor Beta 1) • IL1B (Interleukin 1, beta)
2ms
Capicua regulates the survival of Cajal-Retzius cells in the postnatal hippocampus. (PubMed, Cell Death Dis)
Additionally, we reveal that FGF1 and BCL2 serve as pivotal regulators enhancing CR cell survival in the postnatal hippocampus. Our findings shed light on a previously unacknowledged role of CIC upstream of FGF signaling and elucidate the apoptosis mechanism governing developmental programmed CR cell death.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • FGF (Fibroblast Growth Factor)
2ms
Vascularisation in 3D bioprinted models: emerging solutions for engineering functional tissues and tumour models. (PubMed, Biofabrication)
Mechanical and biochemical cues, including controlled flow, shear stress, and angiogenic factor gradients, are presented as key regulators of vascular maturation and perfusion stability. Validation metrics such as perfusion stability, oxygenation profiles, barrier integrity, and drug transport are emphasised as essential for assessing physiological relevance. Emerging technologies, including smart stimuli-responsive bioinks, 4D bioprinting enabling temporal tissue transformation, and AI-assisted adaptive volumetric fabrication, offer promising solutions for context-aware and dynamically regulated vascular systems. Together, this comparative framework guides strategy selection for either long-term regenerative perfusion or the pathophysiological complexity of tumour vascularisation, and provides practical design principles for translating vascularised tissue models toward clinical application and industrial-scale biofabrication.
Journal
|
FGF (Fibroblast Growth Factor)
2ms
Relationship Between the Levels of 91 Circulating Inflammatory Proteins and Ovarian-Related Diseases: A Bidirectional Mendelian Randomization Study. (PubMed, Int J Womens Health)
Malignant ovarian neoplasms were associated with CCL20 and other markers. This study clarifies the causal relationships between circulating inflammatory markers and ovarian diseases, providing a crucial foundation for future translational research and clinical applications.
Journal
|
IL6 (Interleukin 6) • FGF19 (Fibroblast growth factor 19) • CCL20 (C-C Motif Chemokine Ligand 20) • FGF (Fibroblast Growth Factor) • IL17C (Interleukin 17C) • IL33 (Interleukin 33)